177lu-psma-617
novartis
['crpc']
[177lu]lu-psma-617 in psma-positive #mcrpc: prior and concomitant treatment subgroup analyses of the #vision trial. don't miss, #asco22 presentation by nitin vaishampayan, md jun 5th &gt; 9:12 9:24 am edt 
Largest global online community of #urological medical professionals & patients. #AUA22 #bladdercancer #menshealth #prostatecancer #kidneycancer #Urology